drugset / Trial / NCT00282919

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

NCT00282919

Phase 2 Completed 110 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The treatment of symptomatic, uncomplicated malaria caused by P. falciparum in adults.

Timeline

Start
2006-03
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 2000 mg
Subject Chloroquine Small molecule 600 mg